BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas is participating in a health reform panel discussion for the Capitolbeat Annual Conference in Indianapolis, IN
News | 08. 21. 2009
